miR-146a PREDICTS BETTER OVERALL SURVIVAL AND ACTS AS A TEMOZOLOMIDE (TMZ) SENSITIZER THROUGH TARGETING MULTIPLE SIGNALING PATHWAYS IN GLIOBLASTOMA
- Resource Type
- Journal
- Source
NEURO-ONCOLOGY ; NOV 2018, 20 p47-p48, 2p. Supplement: 6- Subject
- Language
- English
- ISSN
- 15235866